Skip to main content

Table 2 Physiological, experimental, and final calculated parameters for PBPK models established in this study

From: Pharmacokinetics of duloxetine self-administered in overdose with quetiapine and other antipsychotic drugs in a Japanese patient admitted to hospital

Parameter

Abbreviation (unit)

Duloxetine

Flunitrazepam

Quetiapine

Trazodone

Model input parameters

 Molecular weight

MW

297

313

384

372

 Octanol–water partition coefficient

logP

4.26

1.78

2.99

3.85

 Plasma unbound fraction

fu,p

0.114

0.324

0.125

0.0732

 Blood–plasma concentration ratio

Rb

0.843

0.921

0.852

0.805

 Liver–plasma concentration ratio

Kp,h

3.18

1.17

2.69

3.01

 Fraction absorbed × intestinal availability

Fa·Fg

1

1

1

1

 Absorption rate constant

ka (1/h)

0.372 ± 0.007a

2.48 ± 0.05

2.86 ± 0.05

1.12 ± 0.26

 Transfer rate constant

k12 (1/h)

0.28 ± 0.02

 Transfer rate constant

k21 (1/h)

0.04 ± 0.01

 Volume of systemic circulation

V1 (L)

755 ± 1a

80.7 ± 0.1

206 ± 1

66.2 ± 9.5

 Hepatic intrinsic clearance

CLh,int (L/h)

385 ± 1a

15.8 ± 0.1

954 ± 1

173 ± 16

 Hepatic clearance

CLh (L/h)

30.2

4.84

53.4

11.2

 Renal clearance

CLr (L/h)

3.0

0.48

5.3

1.1

Estimated values

 Cmax in plasma

ng/mL

44.9 (0.93)b

9.12 (1.08)

44.2 (0.98)

491 (0.72)

 AUC in plasma

ng·h/mL

1210 (1.19)

52.1 (1.02)

172 (0.95)

3610 (0.77)

Reported levels

 Cmax in plasma

ng/mL

48.5 ± 8.3c

8.47d

45.0e

681 ± 128f

 AUC in plasma

ng·h/mL

1020 ± 220

51.2

181

4670 ± 790

  1. aData are means ± standard deviations by fitting to measured concentrations. bValues in parentheses are ratios to the reported/observed values. Reported/observed blood levels were taken from the literature: c [16], d [17], e [18], and f [19]